UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325
Home » Archive of numbers » 2024 » Volume 32, issue 4 (121) » PSYCHOLOGICAL-PSYCHIATRIC CONSEQUENCES OF ALOPECIA: A STUDY OF PATIENTS’ COGNITIVE FUNCTIONING

PSYCHOLOGICAL-PSYCHIATRIC CONSEQUENCES OF ALOPECIA: A STUDY OF PATIENTS’ COGNITIVE FUNCTIONING

Authors

Type of Article

  • Scientific Article

In the Section

  • diagnosis and treatment of mental and behavioral disorders.

Key words

Index UDK:
  • 616.891:616-052:615.851

Abstract

  • The purpose of the work is to study the features of cognitive functioning of patients withdifferent types of alopecia, to understand the targets of medical and psychological rehabilitation of this contingent.The study included 153 women diagnosed with diffuse alopecia. Depending on the stateof the mental sphere and the genesis of alopecia, 6 subgroups were formed: patients withmetabolic alopecia without signs of maladaptation-G1-1 (30 patients), with metabolic alopecia with individual signs of maladaptation (risk group)-G1-2 (9), with metabolic alopecia andthe presence of adaptation disorders-G1-3 (6 patients), with mixed alopecia without signsof maladaptation-G2-1 (15 patients), with mixed alopecia with separate signs of maladaptation(risk group)-G2-2 (64) and with mixed adaptation and adaptation disorders-G2-3 (29 patients).Affection of patients with alopecia by disorders of cognitive functioning is significant, andmore significant in patients with mixed alopecia.The most common symptoms from the cognitive sphere are rapid fatigue, decreased performance, and impaired concentration.In both metabolic and mixed alopecia patients, cognitive impairment was more oftendetected in patients with adaptation disorders, and less often in patients at risk and withoutsigns of PD. At the same time, the patterns of cognitive impairment in alopecia are complex,nonlinear, and require further study.Prospects for further research are related to the search for connections between cognitiveimpairment in different forms of alopecia with various clinical and psychosocial factors, as wellas the development of personalized measures to correct cognitive impairment in the structureof medical and psychological rehabilitation of patients with alopecia.

Pages

  • 32-35

Year / Issue

Download PDF

Bibliography

1. Piraccini BM, Alessandrini A. Androgenetic alopecia. G ItalDermatol Venereol. 2014 Feb;149(1):15-24. PMID: 24566563.
2. Psychodermatology. Medical andpsychological aspects of the effects of psychosocial stress in clinicaland aesthetic dermatological practice: a collective monographedited by Prof. M. V. Markova, Dr. Med. Sci. I. R. Mukharovska.Kharkiv: Madrid Printing House, 2019. 277 p. (In Ukrainian).
3. Dhami L. Psychology of Hair Loss Patients and Importanceof Counseling. Indian J Plast Surg. 2021 Dec 31;54(4):411-415.doi: 10.1055/s-0041-1741037.
4. Aldhouse NVJ, Kitchen H, Knight S, Macey J, Nunes FP,Dutronc Y, et al. “‘You lose your hair, what’s the big deal?’ I wasso embarrassed, I was so self-conscious, I was so depressed:”a qualitative interview study to understand the psychosocial burden of alopecia areata. J Patient Rep Outcomes. 2020Sep 11;4(1):76. doi: 10.1186/s41687-020-00240-7.
5. Aukerman E.L., Jafferany M. The psychological consequences of  androgenetic alopecia: A  systematic review  //J Cosmet Dermatol. 2023. 22(1). 89-95. doi: 10.1111/jocd.14983.
6. Titeca G, Goudetsidis L, Francq B, Sampogna F, Gieler U,Tomas-Aragones L, et al. ‘The psychosocial burden of alopeciaareata and androgenetica’: a cross-sectional multicentre studyamong dermatological out-patients in 13 European countries.J Eur Acad Dermatol Venereol. 2020 Feb;34(2):406-411. doi:10.1111/jdv.15927. Erratum in: J Eur Acad Dermatol Venereol.2020 May;34(5):1119. doi: 10.1111/jdv.16298.
7. Huang C., Fu Y., Chi C. Health‐related quality of life, depression, and self‐esteem in patients with androgenetic alopecia:a systematic review and meta‐analysis. JAMA Dermatol. 2021Aug 1;157(8):963-970. doi: 10.1001/jamadermatol.2021.2196.
8. Zac RI, da Costa A. Patient satisfaction and quality of lifeamong adult women with androgenetic alopecia using 5 %topical minoxidil. J Clin Aesthet Dermatol. 2021 May;14(5):26-30. PMID: 34188746; PMCID: PMC8211325.
9. Mesinkovska N, King B, Mirmirani P, Ko J, Cassella J.Burden of illness in alopecia areata: a cross-sectional onlinesurvey study. J Investig Dermatol Symp Proc. 2020 Nov;20(1):S62-S68. doi: 10.1016/j.jisp.2020.05.007.
10. Marahatta S, Agrawal S, Adhikari BR. PsychologicalImpact of Alopecia Areata. Dermatol Res Pract. 2020Dec24;2020:8879343. doi: 10.1155/2020/8879343.
11. Torales J, Castaldelli-Maia JM, Ventriglio A, Almirón-Santacruz J, Barrios I, O’Higgins M, et al. Alopecia areata: A psychodermatological perspective. J Cosmet Dermatol. 2022Jun;21(6):2318-2323. doi: 10.1111/jocd.14416.
12. Toussi A, Barton VR, Le ST, Agbai ON, Kiuru M. Psychosocial and psychiatric comorbidities and health-related qualityof life in alopecia areata: a systematic review. J Am Acad Dermatol. 2021 Jul;85(1):162-175. doi: 10.1016/j.jaad.2020.06.047.
13. Tzur Bitan D, Berzin D, Kridin K, Cohen A. The  association between alopecia areata and anxiety, depression,schizophrenia, and bipolar disorder: a population-based study. Arch Dermatol Res. 2022 Jul;314(5):463-468. doi: 10.1007/s00403-021-02247-6.
14. Macbeth AE, Holmes S, Harries M. Chiu WS, et al. The associated burden of mental health conditions in alopecia areata:a population-based study in UK primary care. British Journalof Dermatology. 2022;187:73–81. doi: 10.1111/bjd.21055.
15. Senna M, Ko J, Glashofer M, et al. Predictors of quality of life in patients with alopecia areata. J Invest Dermatol.2022. Oct;142(10):2646-2650.e3. doi: 10.1016/j.jid.2022.02.019.
16. Gelhorn HL, Cutts K, Edson-Heredia E, et  al. The  relationship between patient-reported severity of  hair lossand health-related quality of  life and treatment patternsamong patients with alopecia areata. Dermatol Ther. 2022Apr;12(4):989-997. doi: 10.1007/s13555-022-00702-4.
17. Mesinkovska N, Craiglow B, Ball SG, Morrow P, Smith SG,Pierce E, Shapiro J. The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata. Dermatol Ther (Heidelb).2023 Jul;13(7):1503-1515. doi: 10.1007/s13555-023-00941-z.
18. King BA, Senna MM, Ohyama M, Tosti A, Sinclair RD,Ball  S, et  al. Defining severity in  alopecia areata: currentperspectives and a  multidimensional framework. DermatolTher (Heidelb). 2022 Apr;12(4):825-834. doi: 10.1007/s13555-022-00711-3.
19. King BA, Mesinkovska NA, Craiglow B, et al. Developmentof the alopecia areata scale for clinical use: results of an academic-industry collaborative effort. J Am Acad Dermatol. 2022Feb;86(2):359–364. doi: 10.1016/j.jaad.2021.08.043.

Journal’s Indexing:

UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine

ДУ «ІНПН імені
П.В. ВОЛОШИНА
НАМН УКРАЇНИ»